Background. Little is known about how chronic conditions other than prematurity, heart disease, and Down syndrome affect the risk and severity of hospitalization for respiratory syncytial virus (RSV). We assess the risk and severity of RSV hospitalization in children with chronic conditions in this register-based, population-based cohort study.
Respiratory syncytial virus (RSV) is the most important cause of lower respiratory tract infection leading to hospitalization in infants and young children [1] . At the age of 2 years, virtually all children have been infected and 50% have had the infection twice [2] . Of all infants, 1%-3% require hospitalization [3] [4] [5] [6] . However, preterm infants with or without chronic lung disease, children with heart disease, and children with Down syndrome have much higher rates of RSV hospitalization [7] [8] [9] [10] .
However, clinicians are aware that other chronic conditions may be associated with increased rates of RSV hospitalization, and it is already known that children with neuromuscular diseases have more severe courses during RSV hospitalization [11] . Hence, we designed a population-based cohort study in almost 400 000 children in Denmark to study the risk and severity of RSV hospitalization in children with chronic conditions.
MATERIALS AND METHODS

Design
The study was a register-based cohort study designed to assess the risk and severity of RSV hospitalization in all children born in Denmark from January 1997 through June 2003. The study was approved by the Danish Data Protection Board (No. -41-2496 ).
Databases
The Danish RSV database contains the results of all RSV tests obtained in Denmark in hospitalized patients from January 1997 through June 2003. The Danish National Patient Registry (DNPR) contains all hospitalization dates, discharge dates, operation codes, and discharge diagnoses on all patients discharged from all hospitals in Denmark. The diagnosis coding is based on the International Classification of Diseases, Tenth Revision (ICD-10). Operation codes are based on the Nordic Classification of Surgical Procedures. The Danish National Birth Registry has data on gestational age at birth, mode of delivery, maternal smoking during pregnancy, and single parenthood. The Danish Civil Registration System keeps daily updated information on demographics on all residents in Denmark. In this database each person residing in Denmark has a unique identification number, the Central Person Registry Number, which serves as a key reference to the individual in all public registries in Denmark.
Exposure
Chronic conditions were analyzed in groups based on anatomy and physiology and some single disease entities. Thus, separate analyses were performed on cleft lip and palate, bronchopulmonary dysplasia, cystic fibrosis, esophageal malformations, congenital diaphragmatic hernia, spinal muscular atrophy, muscular dystrophy, Down syndrome, fetal alcohol syndrome, interstitial lung disease, and gastroesophageal reflux. Cardiac diagnoses were included only if they had been established at 1 of the 3 centers for pediatric cardiology in Denmark. Major surgery was entered as cardiac, thoracic, or abdominal.
Outcome
Three outcome variables were studied: (1) RSV hospitalization as defined by the first positive RSV test in the RSV database during the first 2 years of life; (2) duration of RSV hospitalization; and (3) death from RSV infection.
Confounders
The following parameters were entered into the analysis as potential confounders: maternal smoking during pregnancy; single parenthood; presence of siblings; prematurity (gestational age at birth ,37 weeks); birth by cesarean section; an asthma diagnosis (ICD-10 codes J45.0-9) up to 2 weeks before RSV hospitalization; and hospitalization due to other cause within the last 30 days.
Use of Palivizumab
Information on the use of palivizumab in Denmark during the study period was obtained from the Danish Registry of Medicinal Product Statistics.
Statistical Methods
All analyses were done using Stata 11 software. The associations between chronic conditions and first RSV hospitalization were analyzed using a Cox regression model stratified for sex and exact date of birth using age as the underlying time variable. The associations are reported as incidence rate ratios (IRRs) with 95% confidence intervals (CIs) (Wald type). Congenital chronic conditions including bronchopulmonary dysplasia were entered into the analysis as present from birth irrespective of the age at diagnosis (ie, as binary time-fixed variables). Acquired chronic conditions were binary time-varying variables changing from not present to present at the age of first diagnosis. The variables presence of siblings, asthma diagnosis up to 2 weeks before RSV hospitalization, hospitalization within the last 30 days, and major surgery were all entered as time-varying covariates, whereas maternal smoking during pregnancy, single parenthood, prematurity, and cesarean section were time-fixed variables. All variables were entered in 1 final multivariable model with no variable selection procedures. Thus, chronic conditions were adjusted for each other and for all potential confounders in 1 single model. Variables with missing values were treated as an extra category of the respective variable. Proportionality assumptions in the Cox model were tested using Schoenfeld residuals.
Duration of RSV hospitalization in days was analyzed as a quantitative variable in a linear regression after logarithmic transformation due to nonnormality. The associations between chronic diseases and duration were transformed back to the original scale of days and reported as geometric mean ratios with 95% CIs. Four hundred seventy-two children who were nosocomially infected (ie, had a positive RSV test $3 days after hospitalization due to other cause) [12] , were excluded from the analysis of impact of chronic diseases on length of hospitalization. Likewise, 262 children with insufficient data on duration on hospitalization in the DNPR were excluded from this part of the analysis.
RESULTS
The overall study population consisted of 452 205 children aged 0-23 months. During the study period, 12 498 (2.8%) had a first episode of RSV hospitalization. After stratifying by sex and exact date of birth, 4742 strata were generated, corresponding to twice (because of sex) the number of days in the study period. Among the 4742 strata, 4091 had at least 1 child hospitalized with RSV. The median number of children per strata was 96 (interquartile range, 86-106). Six hundred fifty-one strata without RSV hospitalizations were excluded from the analysis. A total of 391 983 children contributed to the analysis. A total of 10 616 (2.7%) had at least 1 diagnosis for chronic disease. Of the children hospitalized with RSV, 930 (8.8%) had a diagnosis for chronic disease.
Children with chronic diseases were older than otherwise healthy children when hospitalized with RSV (median, 7.9 months vs 6.2 months; P 5 .001). The IRRs for RSV hospitalization for children with any congenital of acquired chronic condition were 2.18 (95% CI, 2.01-2.36) and 2.25 (95% CI, 1.94-2.61), respectively.
When assessing the risk of RSV hospitalization in children with congenital chronic conditions apart from already known risk factors for RSV hospitalization, this study shows that cleft lip and palate, malformations of the respiratory system and esophagus, neuromuscular disease, malformations of the urinary system (including vesicoureteral reflux and obstructive renal disease), other intra-abdominal malformations (including malformations of the abdominal wall), chromosomal abnormalities other than Down syndrome, congenital immunodeficiencies, and inborn errors of metabolism are all associated with an increased risk of RSV hospitalization (Table 1) . Among acquired conditions, the rates of RSV hospitalization were 6-fold higher in patients with interstitial lung disease, 4-fold higher in those with liver disease, and at least 2-fold higher in those with epilepsy, acquired heart disease, and cancer ( Table 2 ). The duration of RSV hospitalization was increased in children with bronchopulmonary dysplasia, malformations of esophagus, congenital heart disease, Down syndrome, and in some neuromuscular diseases (Table 3 and 4) .
With respect to major surgery, only children who had undergone cardiac surgery .3 months before were at increased risk of RSV hospitalization (IRR, 1.59 [95% CI, 1.20-2.10]; P 5 .001). Seven of 11 764 nonnosocomially RSV-infected children died during their course of RSV hospitalization. Of these, 1 had neurological disease, 2 had Edwards syndrome, 1 had multiple malformations, and 1 was coded as having malformations without specification. During the study period, 118 children received $1 doses of palivizumab.
DISCUSSION
This national population-based study is the first study that systematically assesses the risk of RSV hospitalization in infants and young children with chronic conditions. We identify several new chronic conditions as independent risk factors for RSV hospitalization, and we also show that many chronic conditions are associated with an increased duration of RSV hospitalization. We furthermore confirm Down syndrome and cystic fibrosis as important risk factors for RSV hospitalization.
A limitation of register-based studies like this is their dependence on registered but not validated diagnostic codes in the databases used, which make these studies vulnerable to misclassification. However, diagnostic misclassification is likely to be nondifferentially distributed among children with and without RSV hospitalization, and misclassification should therefore not bias the relative estimates reported here. In addition, the Danish RSV database from which we identified cases of RSV hospitalization has been evaluated against the DNPR, and it was found that 96% of cases registered with an RSV-specific diagnosis in DNPR were registered in the independent RSV database [13] . Likewise, we find it unlikely that major diseases such as cystic fibrosis, major malformations, and cancer are coded erroneously.
However, misclassification of some chronic diseases cannot be ruled out as a source of bias. Thus, we found epilepsy to be independently associated with a 2.6-fold increased risk of RSV hospitalization and a 1.6-fold increased duration of RSV hospitalization. Although we do not ascribe a causal relationship between epilepsy and RSV hospitalization, we believe that epilepsy in the young age group studied here is a marker for other underlying neurological disease such as cerebral palsy, which in itself is identified as an independent risk factor for RSV hospitalization.
Another limitation of this study is that during the study period, antigen testing was used for diagnosing RSV infection. These tests have a lower sensitivity than the polymerase chain reaction, which is now widely used, and therefore we may well have underestimated the absolute number of RSV hospitalizations, although the relative estimates are unlikely to have been affected.
A factor that might influence the rate of admission for RSV is the threshold for admission, which may vary between countries. For instance, we found that 19.5% of children with Down syndrome were admitted with RSV before the age of 2 years, which is twice the rate reported in a Dutch study [7] . Because the Netherlands and Denmark are comparable with respect to economy, social conditions, and climate, this difference might partly be explained by a difference in the threshold for admission. However, the fraction of 2.8% hospitalized for RSV in the total study population is in accordance with 3 US studies [3, 5, 14] , so we find it unlikely that the very high rates of RSV admissions among groups of children with chronic conditions reported here to any higher degree is explained by a low threshold for RSV admission in Denmark.
Although we adjusted for hospitalization within the last 30 days, we cannot rule out the possibility that the increased risk of RSV hospitalization in some chronic conditions identified here may partly be explained by frailty in the chronically diseased children, and a lower threshold for RSV testing in these children. Thus, we found inborn errors of metabolism to be an independent risk factor for RSV hospitalization, but we do not find a biological explanation that RSV infection should have a more severe course in these children. Rather, we believe that this finding is due to the fact that many children with inborn errors of metabolism do not tolerate fasting and therefore despite relatively mild infection are often hospitalized. Cleft lip and palate was an independent risk factor for RSV hospitalization. It is well known that these children have a very high incidence of middle ear disease [15] , and a recent study also identified cleft palate as a risk factor for RSV hospitalization [16] . The reason for this association is unclear, but we speculate that difficulties in swallowing could lead to aspiration of infected nasal secretion, leading to lower respiratory tract infection.
In children with esophageal malformations, both the risk and the duration of RSV hospitalization were comparable to that found in children with bronchopulmonary dysplasia. Although not reported before, this was not an unexpected finding, because it is well known that children who have undergone surgical repair for esophageal atresia often suffer from persistent respiratory morbidity [17] . Many of these children also have reduced pulmonary function [18] . Among other factors, this may result from lung injury induced by ventilatory support [17] , tracheomalacia [19] , and gastroesophageal reflux [20] . In addition, we found both malformations of the airways and gastroesophageal reflux to be independent risk factors for RSV hospitalization.
An increased risk of RSV hospitalization was also found in children with abdominal malformations. The reason for this is not entirely clear, but gastroesophageal reflux also occurs with a high frequency in children with both omphalocele and gastroschisis [21] , and patients treated for omphalocele often suffer long-term respiratory morbidity [22] . Furthermore, it has been suggested that polycystic kidney and liver disease and biliary atresia may be markers of ciliary dysfunction, a potential explanation for this observation [23] .
Surfactant proteins A and D are important components of the pulmonary innate immune system and are necessary for maintaining a normal surface tension in alveoli. Deficiency of these proteins develops in severe RSV infection [24] , and this may partly explain our finding of a highly increased risk of RSV hospitalization in children with cystic fibrosis. Hence, compared with healthy controls, children with cystic fibrosis have lower levels of both proteins in bronchoalveolar lavage fluid [25] . In a mouse model, it has also been demonstrated that RSV facilitates acute colonization of the airways with Pseudomonas aeruginosa [26] , which is a major pathogen in the lungs of children with cystic fibrosis. Because onset of initial colonization and chronic infection with P. aeruginosa is clearly related to the winter season [27] , it is possible that the acquisition of P. aeruginosa and possibly other bacterial pathogens may be mediated by respiratory viral infections.
We confirm Down syndrome as a major risk factor for RSV hospitalization [7] , and we furthermore show that in children with Down syndrome RSV hospitalization is twice as long as in healthy children. In children with Down syndrome, laryngotracheomalacia is thought to contribute to the respiratory morbidity [28] , but lung hypoplasia [29] and immunological abnormalities such as low absolute numbers of B cells and T cells and defective T-cell and natural killer-cell responses [30, 31] may also be responsible for the increased susceptibility to infections in these children.
To our knowledge, this is the first study to definitively show that children with neuromuscular diseases are at increased risk of RSV hospitalization. Thus, children with congenital malformations of the nervous system, children with cerebral palsy, and children with muscular dystrophy, as well as children coded with the diagnoses of epilepsy, were at increased risk of RSV hospitalization. In addition, neuromuscular diseases were associated with longer RSV admissions, which is in accordance with a previous study demonstrating that children with neuromuscular impairment are at increased risk of a complicated course when hospitalized with RSV [11] . It is possible that factors such as reduced vital capacity due to muscular dysfunction or spastic scoliosis, disturbed clearance of respiratory secretions, and recurrent microaspirations contribute to the increased respiratory morbidity seen in these children [32] . A surprising finding was that children with malformations of the urinary system were at increased risk of RSV hospitalization. This association could partly be explained by pulmonary hypoplasia resulting from oligohydramnios, as seen, for instance, in connection with lower urinary tract obstruction [33] . However, there are experimental data to support that pulmonary and renal fetal growth share a range of morphogenetic processes and signaling pathways [34] . Likewise, a murine model has suggested that abnormal lung development precedes oligohydramnios [35] . Hence, it is possible that unilateral urinary malformations could also be associated with lung problems. Although clinical data on lung function in children with urinary malformations are sparse, 1 study in children with lower urinary tract obstruction showed that half of these children, despite prenatal vesicoamniotic shunting, suffered long-term respiratory symptoms [36] .
Another unexpected finding was that children with liver disease had a 4-fold increased risk of RSV hospitalization. We are not aware of studies linking pediatric liver disease with respiratory tract infection, but 1 study showed that chronic carriers of hepatitis B virus had an increased prevalence of atopic disease [37] , which in itself may be associated with an increased risk of RSV hospitalization [38] .
In children with cancer, we also noted an increased rate of RSV hospitalization in accordance with previous studies [39, 40] . In particular, chemotherapy-induced lymphopenia [39] is believed to contribute to the increased morbidity from RSV infection in these children. Our inability to demonstrate an increased severity of RSV infection, as determined by duration of RSV hospitalization in the present study, may well be due to small numbers, because a large fraction of children with cancer and RSV were nosocomially infected, and these children were excluded from the analysis of the impact of chronic disease on length of RSV hospitalization.
In conclusion, we have identified several new chronic conditions, both congenital and acquired, as independent risk factors for RSV hospitalization.
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